GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Return-on-Tangible-Asset

Laboratorio Farmaceutico Erfo SpA (FRA:RK7) Return-on-Tangible-Asset : 2.00% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Laboratorio Farmaceutico Erfo SpA's annualized Net Income for the quarter that ended in Dec. 2024 was €0.13 Mil. Laboratorio Farmaceutico Erfo SpA's average total tangible assets for the quarter that ended in Dec. 2024 was €6.40 Mil. Therefore, Laboratorio Farmaceutico Erfo SpA's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was 2.00%.

The historical rank and industry rank for Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset or its related term are showing as below:

FRA:RK7' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.46   Med: 18.23   Max: 29.19
Current: 5.46

During the past 6 years, Laboratorio Farmaceutico Erfo SpA's highest Return-on-Tangible-Asset was 29.19%. The lowest was 5.46%. And the median was 18.23%.

FRA:RK7's Return-on-Tangible-Asset is ranked better than
62.34% of 1933 companies
in the Consumer Packaged Goods industry
Industry Median: 3.62 vs FRA:RK7: 5.46

Laboratorio Farmaceutico Erfo SpA Return-on-Tangible-Asset Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Return-on-Tangible-Asset Chart

Laboratorio Farmaceutico Erfo SpA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
Get a 7-Day Free Trial 24.79 25.15 11.66 7.75 5.74

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.39 11.96 3.44 8.47 2.00

Competitive Comparison of Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset

For the Packaged Foods subindustry, Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset falls into.


;
;

Laboratorio Farmaceutico Erfo SpA Return-on-Tangible-Asset Calculation

Laboratorio Farmaceutico Erfo SpA's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=0.353/( (6.571+5.727)/ 2 )
=0.353/6.149
=5.74 %

Laboratorio Farmaceutico Erfo SpA's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=0.128/( (7.082+5.727)/ 2 )
=0.128/6.4045
=2.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2024) net income data.


Laboratorio Farmaceutico Erfo SpA  (FRA:RK7) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Laboratorio Farmaceutico Erfo SpA Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Farmaceutico Erfo SpA Business Description

Traded in Other Exchanges
Address
Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049
Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines